http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_416c92709ad6340cc5ad2e87112e09cb
Outgoing Links
Predicate | Object |
---|---|
family-name | Hess |
name | Sibylle Hess |
given-name | Sibylle |
organization-name | Haemostasis Research Unit, Kerckhoff-Klinik, MPI, D-61231 Bad Nauheim, Germany Sanofi Aventis Deutschland GmbH, Research and Development Division, Translational Medicine and Early Development, Biomarkers and Clinical Bioanalyses, Frankfurt, Germany; and R&D, Translational Medicine & Early Development, Biomarkers & Clinical Bioanalyses, Sanofi Aventis Deutschland GmbH, Frankfurt, Germany Research and Development Diabetes, Sanofi Aventis Deutschland GmbH, Frankfurt, Germany. Sanofi-Aventis Deutschland GmbH, R&D, Translational Medicine & Early Development, Biomarkers & Clinical Bioanalyses, Frankfurt am Main, Germany Sanofi Aventis Deutschland GmbH, Translational Medicine and Early Development, Biomarkers and Clinical Bioanalyses, Frankfurt, Germany (S.H.). Sanofi Aventis Deutschland GmbH, Research and Development Division, Translational Medicine and Early Development, Biomarkers and Clinical Bioanalyses, Frankfurt, Germany Morphochem AG, Gmunder Strasse 37−37a, 81379 München, Germany Sanofi Aventis Deutschland GmbH, Research and Development Division, Translational Medicine and Early Development, Biomarkers and Clinical Bioanalyses, Frankfurt 65926, Germany Sanofi-Aventis Deutschland GmbH, Research & Development , 65926 Frankfurt, Germany 6Global Medical Diabetes, Sanofi, Frankfurt, Germany From the Deutsches Herzzentrum und Medizinische Klinik der Technischen Universität München (G.B., I.S., B.S., A.S., I.O.); and Morphochem AG (S.H., R.E.), München, Germany. R&D Metabolism and PK Germany, Sanofi-Aventis Deutschland GmbH, Frankfurt, Germany. Sanofi-Aventis Deutschland GmbH, Research & Development , Frankfurt, Germany R&D, Translational Medicine and Early Development, Biomarkers and Clinical Bioanalyses, Sanofi-Aventis Deutschland GmbH, Frankfurt, Germany Sanofi Global Medical Diabetes Frankfurt Germany 2Global Medical Diabetes, Sanofi-Aventis Deutschland GmbH, Frankfurt, Germany Global Medical Diabetes, Sanofi, Frankfurt, Germany Translational Medicine and Early Development, Biomarkers and Clinical Bioanalyses, Sanofi-Aventis Deutschland GmbH, Germany From the Deutsches Herzzentrum und 1. Medizinische Klinik (I.S., G.B., A.S., I.O.), Technische Universität München, Germany; Morphochem AG München (R.E.), Germany; Morphochem AG Basel (H.S.), Switzerland; the Department of Vascular Surgery (H.P.M., R.B.), Krankenhaus München-Schwabing, Germany; the Institut für Pathologie (S.S.), Technische Universität München, Germany; and Sanofi-Aventis Deutschland GmbH (S.H.), Frankfurt, Germany. R&D, Translational Medicine and Early Development, Biomarkers and Clinical Bioanalyses, Sanofi Aventis Deutschland GmbH Frankfurt, Germany (S.H.). |
Incoming Links
Showing number of triples: 1 to 64 of 64.